Efficacy and safety of a transdermal contraceptive system

Obstetrics and Gynecology

Volumn 98, Issue 5, 2001, Pages 799-805

  Smallwood, Geoffrey H ^a,b   Meador, Mary L ^a,b   Lenihan, John P ^a,b   Shangold, Gary A ^a,b   Fisher, Alan C ^a,b   Creasy, George W ^a,b  

^a RW Johnson Pharmaceutical Research Institute ^*  (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DRUG METABOLITE; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORGESTIMATE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BREAKTHROUGH BLEEDING; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; MULTICENTER STUDY; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; TREATMENT FAILURE;

ADMINISTRATION, CUTANEOUS; CONTRACEPTIVE AGENTS, FEMALE; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; PREGNANCY;

EID: 0034766473     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01534-4     Document Type: Article

References (25)

1. Current reversible contraceptive methods: A global perspective
2. Trends in contraceptive use in the United States: 1982-1995
3. Contraceptive failure rates; new estimates from the 1995 National Survey of Family Growth
4. Contraceptive failure, method-related discontinuation and resumption of use: Results from the 1995 National Survey of Family Growth
5. Compliance, counseling and satisfaction with oral contraceptives: A prospective evaluation
6. Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation
7. Measuring compliance among oral contraceptive users
8. Transdermal administration of oestrogen/progestagen hormone replacement therapy
9. Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients
10. A norgestimate-containing oral contraceptive: Review of clinical studies
11. Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials
12. Evaluation of a new generation of oral contraceptives
13. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives
14. A nomograph method for assessing body weight
15. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: A randomized controlled trial
16. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives
17. Contraceptive efficacy
18. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception
19. Contraception. A clinical review for the internist